2016
DOI: 10.1146/annurev-economics-080315-015317
|View full text |Cite
|
Sign up to set email alerts
|

Health Care Spending: Historical Trends and New Directions

Abstract: NBER working papers are circulated for discussion and comment purposes. They have not been peerreviewed or been subject to the review by the NBER Board of Directors that accompanies official NBER publications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
7
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(8 citation statements)
references
References 126 publications
1
7
0
Order By: Relevance
“…The results suggest that providing higher payment does not lead to an improvement in various aspects of hospital services. On the contrary, I find evidence that hospitals facing a price increase are more liable to the perverse incentives that the PPS is known to encourage, namely, selecting or shifting patients into higher‐paying diagnosis codes (Chen & Goldman, ). By contrast, previous theoretical works (Chalkley & Malcomson, ; Hodgkin & McGuire, ) predict that an increase in fixed payment under the PPS can lead to quality improvement, provided that the improvement in quality is followed by increased demand.…”
Section: Resultsmentioning
confidence: 99%
“…The results suggest that providing higher payment does not lead to an improvement in various aspects of hospital services. On the contrary, I find evidence that hospitals facing a price increase are more liable to the perverse incentives that the PPS is known to encourage, namely, selecting or shifting patients into higher‐paying diagnosis codes (Chen & Goldman, ). By contrast, previous theoretical works (Chalkley & Malcomson, ; Hodgkin & McGuire, ) predict that an increase in fixed payment under the PPS can lead to quality improvement, provided that the improvement in quality is followed by increased demand.…”
Section: Resultsmentioning
confidence: 99%
“…Under pressure to curb rising health care costs in the US [1], private and public payers, policymakers, clinical societies, and other stakeholders have increasingly turned to formalized health technology assessments (HTA) to assess the relative value of health interventions [2][3][4]. Health economic (HE) modeling [5] is used to predict and compare the costs and health outcomes of interventions and is commonly utilized to inform HTA outside the US [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…-Caregiver burden OutputThe model should offer a range of model outputs that decision makers can reference in decision making -QALY is a commonly used but imperfect measure -Consider clinically based outcome measures such as 'number of responders', or 'number of remitters' Other considerations As the IVI model seeks to incorporate patient-important value elements in the model design, such elements might change over time through the course of their treatment experiences CE cost effectiveness, HAM-D Hamilton Depression Rating Scale, HE health economic, MADRS Montgomery-Asberg Depression Rating Scale, MDD major depressive disorder, PHQ-9 Patient Health Questionnaire-9, QALY quality-adjusted life-years1 "Appendix 1" in the electronic supplementary material (ESM) describes briefly how the AG members were identified and recruited. Please note some members represent multiple stakeholder perspectives.…”
mentioning
confidence: 99%
“…Health care expenditures in the United States (US) represent more than 19% of its gross domestic product. This is approximately twice that of other high-income countries, with a similar outcome in life expectancy [1,2,3]. Advanced imaging, including computed tomography (CT) and magnetic resonance imaging (MRI), strongly contributes to health care costs.…”
Section: Introductionmentioning
confidence: 99%